American scientists are preparing for clinical trials of a new vaccine, which they plan to release in the form of tablets. On Thursday, May 14, according to the Daily Mail. According to one of the creators, immunologist Sean Tucker from San Francisco, the vaccine is made from dead adenovirus, one of the causes of the common cold, in which the Tucker team included some genes from COVID-19. The vaccine is currently undergoing laboratory testing for suitability for production.. It is noted that millions of doses of the new vaccine can be produced by the end of the year.. Mice have already been tested and their results have been promising.. In early July, human trials are planned, candidates are already selected. Together with his team of eight, Dr.

Tucker has been working since January seven days a week to offer effective vaccination in the form of tablets.. Successful testing of coronavirus vaccines on macaques was reported the day before.. She protected primates from pneumonia after infection.. Earlier it became known that in Italy they created a vaccine against coronavirus. Studies on mice have given encouraging results, now the next step is human testing. News from Telegram. Subscribe to our channel https: // t. me / korrespondentnet Author: 1.